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The thrombokinase of the blood was recognized  in 1905 by Morawitz  (1). 
Since  the work of Collingwood  and MacMahon in  1912 (2),  a  growing body 
of evidence has suggested that  the active form arises from a  precursor, pro- 
thrombokinase. The history of this topic has been reviewed elsewhere; and the 
possible relation of thrombokinase to the thromboplastic enzyme of Ferguson 
and Erickson (3), and the "solution A" of Tagnon (4) has been discussed (5). 
Thrombokinase can be prepared from crude plasma globulin  (6),  or from 
a plasma protein fraction adsorbed on diatomaceous earth, or from a fraction 
adsorbed on barium sulfate (7, 8). The active kinase is associated with  pro- 
teins  soluble in 0.35,  but precipitable by 0.45  saturated  ammonium  sulfate 
at pH 5.25  (7, 8).  It is heat-labile  (6, 9) and is retained by semipermeable 
membranes used in dialysis (8). 
When  sufficiently  purified  and  concentrated,  thrombokinase  activates 
prothrombin  in  the presence of excess oxalate,  and  without  the addition  of 
accessory  factors.  However,  its  effectiveness  is  multiplied  by  platelets  or 
by brain  cephafin.  In order for platelets or cephalin  to exert this accessory 
effect, ionic calcium is necessary (8,  9).  In  these situations,  thrombokinase 
can  often be replaced  by the  enzyme,  trypsin;  and  other  results  are  com- 
patible with the view that thromboldnase is an enzyme (6, 9-11). These findings 
are  interpreted  as follows.--- 
Basic reaaion 
thrombokinase 
Prothrombin  )  thrombin  Ca  ++  , 
Accessory faaars 
platelet  thromboplastin 
or 
cephalin 
The  evidence,  as  summarized  above, has  gone  far  toward  substantiating 
the  relationship  considered by Macfarlane  in  1947 (12),  "It  is possible  in 
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fact,  that  cephalin,  supposed  by  various  workers  to  represent  'pure 
thromboplastin,' is no more than  a  cofactor with  calcium and  a  proteolytic 
enzyme  (thrombokinase),  potentiating  the  digestion  of  prothrombin  and 
consequent release of thrombin." In further development of this view, Jensen, 
Gray, and  Schaeffer (13)  have repbrted  that  brain  extracts contain  a  heat- 
labile  thrombokinase  and  a  more  stable  accessory  thromboplastin. 
Preparations  of blood  thrombokinase have  shown  some  slight  proteolytic 
activity; but it is not yet certain that this activity is due to thrombokinase, 
per se. And results in this laboratory have not yet shown decisively whether 
cephalin  exerts its  accessory effect as  a  simple  cofactor or  in  a  more  com- 
plicated manner (11, 14). 
In accord with  the enzyme theory,  the present results show  that crystal- 
lized soy bean trypsin inhibitor prevents the formation of thrombin from a 
mixture  of prothrombin  and  blood  thromboldnase.  In  further  characteriza- 
tion  of blood  thrombokinase,  it  has  been  found  that  it  is not  readily  sedi- 
mented by a  centrifugal force of 85,000 g.  It is therein different from certain 
easily  sedimentable  "thromboplastins"  of  tissue  extracts.  Further  experi- 
ments  indicate  that  the  effectiveness  of  thrombokinase  is  multiplied  not 
only by cephalin, but also by an "accelerator" reagent prepared from serum. 
But  here  again,  ionic  calcium  is  required.  In  complemented  or  crude  sys- 
tems,  the  presence of ionic  calcium can increase  the  effectiveness of throm- 
bokinase a hundredfold or more. 
EXPER~rENTAL 
Materials  and Metkods 
Buffer.--0.9  per  cent  sodium  chloride:  0.02  x~ veronal, pH.  7.4  (15). 
Prothrombin.--Prepared from bovine plasma globulin  by adsorption  on  barium 
sulfate and elution with 0.3 M phosphate, pH 6.6  (8),  then passed through a filter- 
cake of standard  super-eel  (16),  dialyzed  against buffer, and  stored at  -20°C. 
Thrmnbokinase.--Prepared from bovine plasma globulin  by adsorption on barium 
sulfate, elufion with 0.6 K phosphate pH 7.9, ammonium sulfate fractionation, and 
dialysis against buffer (8). The concentration of biologic material was approximated 
by drying to constant weight in a vacuum desiccator over phosphorus pentoxide and 
subtracting the weight of the buffer solids. The stock solution was stored at -20°C. 
"Accelerator."---Prepared from frozen bovine plasma, containing  about 0.014 
oxalate. To 905 ml. thawed plasma was added 37.7 ml. 0.5 M calcium chloride.  The 
mixture was stirred continuously for 30 minutes to remove as much fibrin as possible 
on the stirring rod. The serum was stored at 5°C. for 2 days and centrifuged. Then 
300 ml. of supematant serum was mixed with 15 grn. barium carbonate for 15 min- 
utes  at  24°C.  and  centrifuged.  The  supernatant  "barium  carbonate  serum"  was 
stored overnight at 3.5°C. An adsorption column, 19 ram. in diameter and 118 ram. 
high,  was prepared with  10 gm. standard  super-eel  (16),  and washed with 0.9 per J.  H.  rrr~sxo~m  759 
cent sodium  chloride.  At 3.5  4- 0.5°C.,  the "barium carbonate serum" was forced 
through the column by air pressure  at the rate of 23 ml./hour, and fractions of 50 
drops each were collected by an automatic fraction collector. The seventh fraction 
was taken as the "accelerator" reagent. 
Cephalin.--Prepared from bovine brain by the classical method of Howell  (17), 
and stored in evacuated vials at  -20°C. To prepare a stock suspension,  a weighed 
amount was dispersed in buffer. 
Lung Sedime~.--Prepared from bovine lung by a  modification  of the ultracen- 
trifugal method of Chargaff, Bendich,  and Cohen (18). The fraction used was that 
which was sedimented to the bottom of the tube in 120 minutes at 24,000 g, but not 
in 30 minutes at S,000 g. The material was subjected  to three cycles of differential 
centrifugation. 
Soy Bean Trypsin Inhibitor.--Crystallized five times by Worthington Biochemical 
Laboratory, Freehold, New Jersey, according to the method of Kunitz (19). 
Coagulation Tes/s.--Essentially as described  (10). All  tests were performed in a 
water bath  at 28°C. The same  preparation of prothrombin, at the same  concen- 
tration, was used in all tests, except where otherwise noted. The thrombin values, as 
plotted on the charts, were obtained by dividing 3#00 by the clotting time in seconds. 
Tkrombokinase and  Crystallized Soy Bean Inkibitor 
Tagnon and  Soulier reported that  crystallized soy bean  trypsin inhibitor 
had  marked  anticoagulant  activity on  whole  blood,  but  not  on  thrombin- 
fibrinogen mixtures  (20).  Following studies  with  lung  extract and  Russell's 
viper  venom,  Macfarlane  and  Pilling  concluded  that  the  trypsin  inhibitor 
appeared  to  be  a  potent  anti-thrombokinase  (21);  and  later,  Macfarlane 
added further details (12). Glazko found that the trypsin inhibitor interfered 
with  the  thrombin-forming mechanism  (22). 
In  the present experiments it  was  attempted  to limit  the  test system to 
the  thrombokinase-prothrombin  reaction.  Purified  blood  thrombokinase 
and prothrombin were used; and oxalate was added. In the presence of oxa- 
late,  the  accessory factors,  even  if present,  are  not  effective, according  to 
results obtained so far. 
The test mixtures contained prothrombin,  buffer, 0.011  ~  oxalate,  1 rag. 
thrombokinase/ml.,  and  increasing  amounts  of trypsin inhibitor.  As  shown 
in Fig.  1, the trypsin inhibitor, at a  concentration of 100 #g./ml., suppressed 
the  formation  of  thrombin  from  a  mixture  of  prothrombin  and  thrombo- 
kinase.  A  small  amount  of  thrombin  contaminated  the  thrombokinase rea- 
gent;  and  this accounts for the elevation of the baseline, evident in Fig.  1. 
Control tests  showed  that  the  trypsin inhibitor did not retard  the  clotting 
of fibrinogen by thrombin, under the conditions of the experiment. At higher 
concentrations,  the  inhibitor  solution  did  cause  some  delay in  the  clotting 
of fibrinogen. 760  BLOOD  THROMBOKINASE 
Ultracentrifugation  of Tkrombokinase 
Chargaff,  Bendich,  and  Cohen  (18)  used  differential  centrifugation  to 
prepare  their  thromboplastic  protein  from  an  extract  of  bovine  lung.  The 
active factor was recovered in the sediment after centrifugation for 90 minutes 
at  20,000  g.P.~.,  at  a  force stated  to  be  31,000  g.  Similarly,  Chargaff and 
West (23) sedimented a coagulant agent from plasma in 150 minutes at 20,000 
It.P.xc.  Johnson,  Smathers,  and  Schneider  have  found  that  an  important 
component of platelet  extracts is easily sedimentable by forces in  the  range 
of 2,000  g.  (24).  It was important to  determine whether  thrombokinase,  as 
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FIG.  1. Activation of prothrombin by thrombokinase in the presence of 0.011 II 
oxalate,  and  inhibition  by crystallized  soy bean  trypsin inhibitor. 
prepared  from bovine plasma,  could  be  sedimented  as  easily as any of  the 
foregoing agents. 
A  solution  of  thrombokinase, containing  7.3  mg.  non-dialyzable solids  per ml., 
was centrifuged in a Spinco model L ultracentrifuge at 36,000 R.P.M. for 120 minutes. 
With the aid of plastic adapters, 8  X 50 mm. lusteroid tubes were used in a No. 40 
rotor. The average centrifugal force was about 85,000 g. At the end of the run, the 
top milliliter of supernate was pipetted off, to be tested  against an uncentrifuged 
control. After the remainder of the supernate was decanted, the amber pellet at the 
bottom of the  centrifuge  tube  was suspended  in  a  volume of buffer equal  to  the 
original volume. 
In  the presence of calcium chloride,  the  supemate activated prothrombin 
several times as fast as did the sediment. Tests for activation of prothrombin J.  H.  MILSTONE  761 
in  the  presence  of  oxalate  again  demonstrated  that  most  of  the  thrombo- 
kinase  activity  remained  in  the  supernate  after  centrifugation  at  85,000  g 
for  120  minutes,  as  shown  in  Table  I. 
In a  further experiment, designed  to reduce the effect of occlusion,  most of the 
easily sedimentable material was removed by a preliminary run, and then the super- 
nate was recentrifuged. Both runs were made as in the previous experiment, except 
that the first run was continued for 180 minutes.  After the second  centrifugation, 
for 120 minutes, the top milliliter of the supernate was pipetted off for use in activity 
tests. The small pellet was suspended  in a volume of buffer equal to the original vol- 
ume. To test for thrombokinase activity, mixtures were made, containing 0.6  ml. 
buffer, 0.1 ml. prothrombin, 0.1  ml. 0.025 M calcium chloride,  and 0.2 ml. of either 
supernate or resuspended  sediment. 
TABLE I 
Comparative Activity of the Supernate and Sedianenl Obtained by Ultroxentrifugation 
of Thrombokinase 
Mixtures  Period of incubation 
0.5 ml.  0,1 ml.  0.2 ml.  0.2 ml.  10 mln.  20 min. 
Buffer 
t~ 
Prothrombin  Oxalate 
c¢ 
~t 
Kinase 
Supernate 
Sediment 
5 mln. 
Set:. 
275 
390 
1850 
S~.  $C6. 
150  90 
220  115 
1550  1020 
Oxalate, 0.057 xt potassium oxalate. 
Kinase, uncentrifuged control. 
Each curve in Fig.  2 represents the average of duplicate  tests.  They show 
that the thrombokinase activity of the sediment was small compared to that 
of the supemate.  Further  tests showed  that  the supernatant  thrombokinase 
could  activate  the  supernate  from  a  prothrombin  solution  centrifuged  at 
85,000 g for 120 minutes.  It is concluded that the activation of prothrombin 
by thrombokinase can proceed in the absence of material easily sedimentable 
at  85,000  g. 
Thrombokinase  and  Accessory  Factors 
The studies  of Quick  (25,  26),  Owren  (27,  28),  and  Fantl  and Nance  (29, 
30)  opened up the possibility that plasma might contain  more clotting fac- 
tors than previously recognized. Murphy, Ware,  and  Seegers (31)  confirmed 
the observation of Fantl and Nance  that an accelerator was not readily ad- 
sorbed from oxalated plasma by barium carbonate. Later, Ware and Seegers 
(32)  treated  bovine  serum  with  barium  carbonate  and  used  the  resulting 
serum as an accelerator. 
As described  in  the  section  on  materials and  methods,  bovine serum  was I00- 
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treated with barium carbonate and then passed through a column of standard 
super-cel.  The  seventh  column  fraction did  not  activate  prothromhin,  but 
it did hasten the production of thrombin from prothrombin, in the presence 
of calcium and  lung  sediment  of the  type prepared  by Chargaff,  Bendich, 
and Cohen (18). It therefore possessed the usual attributes of an "accelerator." 
Table  II  shows  the  effect  of  the  "accelerator"  reagent  in  a  com- 
plex thrombin-producing system.  Five-reagent systems have been described 
before (33-37);  but the present system differs from all of them in that  one 
of the components is a  thrombokinase reagent which has been shown to func- 
tion in the presence of oxalate. The first test shows that thrombin was pro- 
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FIG. 2.  Activation of prothrombin by the supernate and sediment obtained by 
centrifuging  thrombokinase at 85,000 g for 120 minutes. Activation tests were per- 
formed in the presence  of 0.0025 x~ calcium  chloride. 
duced  rapidly  when  all  five  reagents  were  present.  Test  2  shows  that 
no thrombin was produced when the thrombokinase was omitted; even though 
all the other reagents were included. In test 3, prothrombin was slowly ac- 
tivated  by  thrombokinase,  even  though  the  cephalin,  "accelerator,"  and 
calcium reagents were omitted.  In test 4,  as compared with  test 3,  the res- 
toration of cephalin and "~ccelerator"  to the system did not accelerate the 
production  of  thrombin,  in  the  absence  of added  calcium  ions. 
When prothrombin was omitted, as in test 5, the remainder of the system 
revealed a  slight  contamination with  thrombin,  which  dwindled during  the 
course of the experiment. This thrombin contaminant was brought into the 
system by the  thrombokinase reagent  (cf.  Fig.  1).  In  test  6,  activation of 
prothrombin  by  thrombokinase  seemed  to  be  faster  with  added  calcium; J.  H.  M'ILSTONE  763 
but  most of this  apparent  effect was due  to  the  influence  of calcium on  the 
dotting  of fibrinogen,  as  demonstrated  previously  (9).  Tests  7  and  8  show 
that  the  separate  effects  of  cephalin  and  "accelerator"  were  not  nearly  as 
great  as  the  effect  of  the  two  together  (test  1). 
Further  inquiry  was made  concerning  the  amount  of  cross-contamination 
among  the  biologic reagents.  This  was done  by beginning  with  the  mixture 
of  test  1  and  reducing  the  concentration  of  each  biologic  component,  one 
at  a  time.  In Figs.  3  a,  b,  c,  and d,  the  uppermost  curve in each  represents 
a  mixture  made  as for  test  1  of Table  II. 
TABLE II 
Fi~e-Reagent  Thrombin-Producing  System 
Test 
No. 
Buffer 
m|. 
0.5 
0.6 
0.8 
0.6 
0.6 
0.7 
0.6 
0.6 
Mixtures  incubation 
Pro- 
thrombin 
0.1 
0.1 
0.1 
0.1 
0.1 
0.1 
0.1 
Cephalin 
0.1 
0.1 
0.1 
0.1 
0.1 
Accel- 
rator" 
ml. 
0.1 
0.I 
O.i 
0.1 
0.1 
CaCh 
mL 
0.1 
0.i 
0.1 
0.1 
0.1 
0.1 
Kinase 
m/. 
0.1 
0.1 
0.1 
0.1 
0.1 
0.1 
0.1 
Period of 
10 rain.  20 mill. 
t-7~.  i  s,c. 
N.C. 
3,0OO  I 2,41111 
N.c.  2,580 
2,580:3,300 
2,400  1,020 
6601  3s0 
118  91 
40 rain.  80 rain. 
$$#.  $¢~, 
27  26 
N.c.  N.c. 
630 
1,380  I  72o 
3,600  I  N.c. 
730 I  385 
225  t  130 
82[  65 
Cephalin, 0.05 per cent suspension.  Final concentration in mixture, 50 #g./mi. 
"Accelerator," 1/50 dilution.  "  "  "  "  2 #l./ml. 
CaCh, 0.025 '~.  "  ....  "  0.0025  ~. 
Kinase, 0.05 per cent solution.  "  "  "  "  50 #g./ml. 
At the specified times, 0.1 mi. of mixture was added to 0.3 ml. oxalated fibrinogen. The 
resulting  clotting times are given in the body of the table. N.c. =  no clot in I hour. 
Fig. 3 a shows that the amount of thrombin formed depended on the amount 
of prothrombin. 
In Fig.  3  b, it is seen that  the  amount  of thrombokinase  reagent  could  be 
reduced  from the  original  50 #g./ml.  to 0.4 ttg./ml,  and still exert an appre- 
ciable effect on  the production  of thrombin.  This indicates  that  the amount 
of  initially  active  thrombokinase  contributed  by  all  the  other  reagents  to- 
gether  was probably  less  than  that  represented  by 0.4 gg.  of the  thrombo- 
kinase  reagent.  In  other  words,  50  gg.  thrombokinase  reagent  probably 
contributed  more  than  125  times  as much  of initially  active  thrombokinase 
as all the other reagents together. 
In Fig. 3  c, the relation is somewhat different,  because activation  occurred 
with  no  added  cephalin.  Nevertheless,  0.4  ttg.  cephalin  did  cause  an  appre- 764  BLOOD THROMBOKINASE 
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FIos. 3 a, b, c, and d.  Effect of reducing  the  concentration of reagents, one  at  a time,  in a 
five-reagent system. Calcium chloride 0.0025 •  in all tests. J.  H.  MILSTONE  765 
ciable  acceleration.  It  may be  concluded that  the  amount of  cephalin-like 
material contributed by all the other reagents together was very small com- 
pared  to the contribution made by 50  #g. cephalin reagent. 
In  the case of the  "accelerator" reagent, the evidence was not nearly so 
clear.  First, the base line, without added "accelerator" was higher, as seen 
in Fig. 3 d. Secondly, it was not possible to reduce the "accelerator" to much 
less than one-eighth of its original amount and still cause significant accel- 
eration. Thirdly, in the course of preparing the "accelerator," other column 
fractions  had  been  collected  and  tested.  Those  fractions,  which  emerged 
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75 
Conc. of Thrombokinase 
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Fzo.  4.  Amount of  thrombokinase  required,  when  complemented  by cephalin, 
calcium, and "accelerator" reagent, to produce an effect comparable to that of 1,000 
~g.  thrombokinase,  uncomplemented. 
from the  adsorption column after  the  seventh  ("accelerator")  fraction, be- 
hayed as  if they contained  thrombokinase or prothrombokinase. 
In  the  system of Table  II,  the  effect of  the  "accelerator" could not  be 
detected unless thrombokinase was added,  even  though  cephalin was pres- 
ent  (test  2  vs.  test  1).  This indicates that  thrombokinase was primary to, 
or  necessary for,  the  action  of  "accelerator," under  the  conditions of  the 
experiment. For the present,  the  "accelerator" may be  considered to com- 
plement  thromboklnase,  possibly  as  another  accessory  factor,  or  possibly 
as  a  potential  source  of  more  thrombokinase. 
If cephalin and "accelerator" are taken as complements for thromhokinase, 
then  it  appears  from  Table  II  that  they  increased  the  effectiveness 
of  thrombokinase  a  hundredfold. There,  thrombin  was produced  about  a 
hundred times as fast in test 1 as in test 6.  Another way of expressing this 
relation is illustrated in Fig. 4. There, the continuous line shows the activa- 766  BLOOD  THROMBOKINASE 
tion of prothrombin by 1,000  #g.  thrombokinase, in the presence of calcium. 
In the other tests,  the  system was complemented by cephalin and  "acceler- 
ator" in the same quantities used in Table II, and thrombokinase was added 
in decreasing amounts. The results are charted by the broken lines in Fig. 4. 
It is seen that 2 #g. thrombokinase had as great an effect in the complemented 
system as 1,000  pg. thrombokinase in the uncomplemented system. 
This  difference  in  the  effectiveness of  thrombokinase  depended  not  only 
on  the  added  cephalin  and  "accelerator;"  it  depended  also  on  the  added 
calcium.  It was shown  in  Table II that  cephalin  and  "accelerator" are not 
effective without  calcium.  In  a  complex or  crude  system,  the  effectiveness 
of thrombokinase is enormously increased by the presence of ionic calcium. 
DISCUSSION 
The results obtained to date in this laboratory together with many others 
(5),  can  be  summarized  as  follows:-- 
Basic clotting mechanism  Accessory factors 
thrombokinase 
1.  Prothrombokinase  ~ thrombokinase  Ca  ++, and ? 
thrombokinase 
2.  Prothrombin  ~ thrombin  Ca  ++,  platelets  and ? 
or cephalin, 
thrombin 
3.  Fibrinogen  ~ fibrin  ? 
The principal distinction between this and other current theories is the designation 
of a  single  factor, thrombokinase, as a  prime prothrombin activator that arises in 
dotting blood.  The present study has a bearing on two questions:  (1) What is the 
evidence that thrombokinase can activate prothrombin without the aid of any other 
factor? (2) Are the known properties of thrombokinase compatible with an important 
physiologic role? 
The present tests with a five-reagent system show that thrombokinase activated 
prothrombin without  the  addition  of calcium,  cephalin,  or "accelerator;" whereas 
the last three reagents did not activate prothrombin without the addition of thrombo- 
kinase. The quantitative tests have made it unlikely that the thrombokinase is con- 
taminated with an appreciable amount of cephalin or cephalin-like  material. Even if 
cephalin had contaminated the thrombokinase, it would have been ineffective  in the 
presence of oxalate. In the present experiments, the mere omission of calcium chloride 
rendered cephalin ineffective. 
The action of thrombokinase in the presence of oxalate also makes it improbable 
that platelets are absolutely necessary; for piatelets have little effect without  the 
addition  of ionic  calcium  (8,  38).  Moreover,  the  present  experiments  show  that 
thrombokinase can function after removal of material easily sedimentable at 85,000 g. 
This procedure would  remove platelet fragments of the type described  by Johnson, 
Smathers, and Schneider  (24) and also tissue  particulates of the type described  by 
Chargaff, Bendich,  and Cohen  (18). J.  H.  MII~TONE  767 
Previous  experiments  (9)  have  demonstrated  that  the  concentration  of oxalate 
could  be  varied  over a  fourfold range without influencing the  action of thrombo- 
kinase,  and  that  thrombokinase  could  function  in  the presence  of 0.5  ~  oxalate. 
Moreover,  addition  of calcium ions caused  little,  if any,  acceleration  of thrombin 
production. 
From the foregoing,  it is concluded that thrombokinase can act without 
cephalin or cephalin-like  material,  without platelets,  without material com- 
pletely  sedlmentable in 120 minutes at 85,000 g, and without ionic  calcium. 
Other conceivable contaminants of thrombokinase remain to be considered. 
Activation  by  the  thrombokinase  reagent  alone  has  been  easily  demonstrable 
only when the thrombokinase was sufficiently purified and concentrated. In Table II, 
thrombokinase functioned alone at a concentration of 50 #g./ml. But thrombin was 
produced  so slowly that the effect might have been missed entirely by a  cursory, 
abbreviated  test. In Fig. 1, thrombin was produced more rapidly, and moreover, in 
the presence  of oxalate.  But  in Fig.  1,  the concentration of thrombokinase  was  1 
mg./ml., twenty times that used in Table II. The contrast is even greater in Fig. 4. 
If the thrombokinase reagent had been tested exclusively  at a concen- 
tration less  than that of Table II, its power to convert prothrombin could 
readily have  been  ignored. It would  have  seemed  to be  a  "new  fac- 
tor,"  capable of acting  only as part of an activator  mixture or complex. 
The results  with purified  thrombokinase are compatible with the role of 
prime physiologic activator.  Beginning with the activation of prothrombin 
by thrombokinase as the basic  reaction,  it has been possible  to superimpose 
other factors known  to be of physiologic importance and to demonstrate 
that their  effects  depended on the presence of thrombokinase. This has pre- 
viously  been done for  platelets  and calcium ions (8, 38).  In the present study, 
the presence of thrombokinase was necessary in order to demonstrate the 
effect of the "accelerator" reagent. If the "accelerator" represents a dis- 
tinct factor and one of physiologic importance, then the results  show that 
its effect  is also superimposed on that of thrombokinase. 
According to the three-stage  formulation,  as presented above, the removal 
of calcium ions  from freshly  drawn blood would depress the production of 
thrombokinase from prothrombokinase (10).  In the second stage,  the system 
would  be deprived  of the  acceleratory effect of platelcts,  and  possibly 
another accessory factor.  Any thrombokinase produced would have to act 
without the benefit  of these accessory effects,  and against the physiologic 
anticoagulant system of the blood. Thus, there  is no contradiction  between 
the fact  that oxalate can keep blood fluid  and the fact  that thrombokinase 
can act in the presence of oxalate.  And the present results  with thrombo- 
kinase are quite consistent  with the physiologic  importance of ionic  calcium 
for the dotting of  blood. 768  BLOOD  THROMBOKINASE 
SUM]~ARY 
1.  Crystallized  soy  bean  trypsin  inhibitor,  at  a  concentration  of 
100  #g./ml.,  suppressed the production of thrombin from a  mixture of pro- 
thrombin  and  blood  thrombokinase.  The experiment was  performed in  the 
presence of 0.011  ~  oxalate, in order to minimize the possibility of partici- 
pation  by accessory factors which  require ionic calcium.  The results  are  in 
accord with  the view that  thrombokinase is a  trypsin-like enzyme. 
2.  When  a  solution  of blood  thrombokinase was  centrifuged at  85,000  g 
for  120  minutes,  almost  all  the  activity remained  in  the  supernate.  This 
supernate  activated  the  supernate  from a  prothrombin  solution  which  had 
been similarly centrifuged. The activation of prothrombin by thrombokinase 
can  proceed  in  the  absence  of  material  completely  sedimentable  in 
120 minutes at 85,000 g. 
3.  An  "accelerator" reagent was  prepared by treating bovine serum with 
barium  carbonate,  and  then passing  the  serum  through  a  column of diato- 
maceous  earth.  This  "accelerator"  was  used  together  with  prothrombin, 
blood  thrombokinase,  Howell's  cephalin,  and  calcium  chloride  to  compose 
a  five-reagent  thrombin-producing  system.  In  this  system,  no  thrombin 
was  produced  without  thrombokinase.  On  the  other  hand,  thrombin  was 
produced  from  prothrombin  and  thrombokinase,  even  when  all  the  other 
reagents were omitted. When calcium was  omitted,  thr0mbokinase was able 
to function; but cephalin and the "accelerator" reagent  were ineffective. 
4.  Quantitative  tests  indicated  that  the  "accelerator"  reagent  exerted 
an  effect distinct  from  those  of  thrombokinase  and  cephalin.  However,  it 
is not certain whether the  "accelerator" reagent functioned as an accessory 
factor, as a  potential source of more thrombokinase, or both.  In the experi- 
ments reported,  thrombokinase was primary to,  or necessary for, the  effect 
of "accelerator." 
5.  The  effectiveness  of  thrombokinase  was  multiplied  a  hundred  times 
or more,  when  complemented by  calcium,  cephalin,  and  "accelerator" rea- 
gent.  Ionic calcium was  a  necessary component of this  complementing sys- 
tem. This may help to explain why removal of calcium ions keeps blood  fluid, 
even  though  thrombokinase,  by itself,  is  little  influenced either by calcium 
ions or by oxalate. 
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